RESULTS OF AN EARLY RETROSPECTIVE ANALYSIS OF THE ASSOCIATION BETWEEN NEUROLOGICAL PROBLEMS AND COVID-19
Keywords:
neurological symptoms and complications of COVID-19, cavernous sinus thrombosis, concomitant diseases, retrospective analysisAbstract
In order to clarify the neurological effects against the background of COVID-19, the neurological symptoms observed in patients with coronavirus infection at the Tashkent multidisciplinary medical center in 2020 and 2022 were studied and summarized. The variety of neurological symptoms of COVID-19 highlights the multifaceted nature of the disease and its impact on the overall health of patients. In addition, the large burden of these neurological complications on the medical system has demonstrated the need to implement specific treatment and monitoring approaches. Therefore, it is important to promptly identify and carry out correct and competent pathogenetic treatment to reduce disability and mortality associated with these symptoms.
References
N. Zhu, D. Zhang, W. Wang, et al., A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med. 382 (2020) 727–733.
World Health Organization Coronavirus Disease (COVID-19), Situation Report- 117, Accessed May 16, 2020 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200516- covid-19-sitrep-117.
A.J. Rodriguez-Morales, J.A. Cardona-Ospina, E. Gutiйrrez-Ocampo, et al., Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis, Travel Med. Infect. Dis. (2020) 101623.
N. Chen, M. Zhou, X. Dong, et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet 395 (2020) 507–513.
Z. Wu, McGoogan JM, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention, JAMA (2020) 1–4.
L. Mao, H. Jin, M. Wang, et al., Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019in Wuhan,China, JAMA Neurol. (2020)1-5.
J. Helms, S. Kremer, H. Merdji, et al., Neurologic features in severe SARS-CoV-2 infection, N. Engl. J. Med. (2020) 1–7.
C.W. Yancy, COVID-19 and African Americans, JAMA (2020) 1–3.
Novel Coronavirus pneumonia diagnosis and treatment plan (Provisional 7th Edition), Accessed April 30, 2020 https://www.chinalawtranslate.com/en/ coronavirus-treatment-plan-7/.
P.Pinna1, P.Grewal1, et all. Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline. Journal of the Neurological Sciences 415 (2020) 116969
L.Q. Li, T. Huang, Y.Q. Wang, et al., COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis, J. Med. Virol. (2020) 1–6.
N. Poyiadji, G. Shahin, D. Noujaim, M. Stone, S. Patel, B. Griffith, COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI features, Radiology (2020) 201187.
A. Virani, E. Rabold, T. Hanson, et al., Guillain-Barrй Syndrome associated with SARS-CoV-2 infection, IDCases (2020) e00771.
C. Gutirrez-Ortiz, A. Mndez, S. Rodrigo-Rey, et al., Miller Fisher Syndrome and polyneuritis cranialis in COVID-19, Neurology (2020) 1–2.
A.M. Baig, A. Khaleeq, U. Ali, H. Syeda, Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms, ACS Chem. Neurosci. 11 (2020) 995–998.
A.M. Baig, Neurological manifestations in COVID-19 caused by SARS-CoV-2, CNS Neurosci. Ther. 26 (2020) 499–501.
K. Bohmwald, Gбlvez NMS, M. Rнos, A.M. Kalergis, Neurologic alterations due to Respiratory Virus Infections, Front. Cell. Neurosci. 12 (2018) 386
